Summit Therapeutics Inc.
SMMT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001599298
No open-market purchases or sales by Summit Therapeutics Inc. insiders were filed in the last 90 days; 242 institutions reported holding it in 13F filings for Q2 2026, worth $1.98B in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Summit Therapeutics Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Of which not filed for Q1 2022 | Q1 2022 | Change |
|---|---|---|---|---|
| Holders | 52 | 1 | 48 | −3 |
| Shares | 11.1M | 1.30K | 11.0M | −96.4K (−0.9%) |
| Value | $30.0M | $3.00K | $27.4M | −$2.60M (−8.7%) |
1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (7)
Institutions that held Summit Therapeutics Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Boothbay Fund Management, LLC | 154,950 | $380.0K | 0.01% |
| Alpine Global Management, LLC | 0 | $380.0K | 0.10% |
| Bridgeway Capital Management, LLC | 129,100 | $316.0K | 0.01% |
| Barclays PLC | 4,361 | $11.0K | 0.00% |
| Amalgamated Bank | 4,291 | $11.0K | 0.00% |
| Amalgamated Financial Corp. | 4,291 | $11.0K | 0.00% |
| FMR LLC | 729 | $2.00K | 0.00% |
Sold out (10)
Institutions that held Summit Therapeutics Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Russell Investments Group, Ltd. | 216,991 | $582.0K |
| Citadel Advisors LLC | 42,593 | $115.0K |
| Two Sigma Securities, LLC | 19,474 | $52.0K |
| D. E. Shaw & Co., Inc. | 15,146 | $41.0K |
| Susquehanna International Group, LLP | 14,461 | $39.0K |
| Virtu Financial LLC | 13,649 | $37.0K |
| SG Americas Securities, LLC | 12,671 | $34.0K |
| Jane Street Group, LLC | 12,143 | $33.0K |
| Simplex Trading, LLC | 1,578 | $4.00K |
| Signaturefd, LLC | 199 | $1.00K |
Not filed for Q1 2022 yet (1)
Institutions that held Summit Therapeutics Inc. at the end of Q4 2021 and haven't filed a 13F for Q1 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Harbour Investments, Inc. | 1,300 | $3.00K |